Top Markets
#1 Beta Finance Beta Finance +16,842.48%
#2 Siren Siren +137.02%
#3 Block Street Block Street +90.04%
#4 DAO Maker DAO Maker +51.04%
#5 MemeCore MemeCore +32.75%
#6 Nockchain Nockchain +28.91%
#7 Layer3 Layer3 +26.97%
#8 dKargo dKargo +20.94%
#9 Amiko Amiko +19.51%
#10 Liquid Mercury Liquid Mercury +19.33%
Coin of the day
Beta Finance Beta Finance
Settings
Language
ENGLISH
Currency
USD
Theme
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Rank in Stocks #429
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health... Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Share Price
$116.36
Market Cap
$51.28B
Change (1 day)
0.37%
Change (1 year)
-27.86%
Country
US
Trade Zoetis Inc. (ZTS)

Category

Healthcare
Revenue for Zoetis Inc. (ZTS)
Revenue in Dec 2025 TTM: $9.47B
According to Zoetis Inc. latest financial reports the company's current revenue (TTM) is $9.47B. In 2024 the company made a revenue of $9.26B an increase over the revenue in the year 2023 that was $8.54B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Zoetis Inc. from 2009 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $9.47B 0.00%
2025 $9.47B 2.28%
2024 $9.26B 8.33%
2023 $8.54B 5.74%
2022 $8.08B 3.91%
2021 $7.78B 16.49%
2020 $6.68B 6.63%
2019 $6.26B 7.47%
2018 $5.83B 9.76%
2017 $5.31B 8.57%
2016 $4.89B 2.58%
2015 $4.77B -0.42%
2014 $4.79B 4.91%
2013 $4.56B 5.19%
2012 $4.34B 2.43%
2011 $4.23B 18.17%
2010 $3.58B 29.78%
2009 $2.76B 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MKGAF.US
 $24.76B 161.50%
DE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPSEY.US
 $4.43B -53.16%
FR
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
TAK.US
 $28.60B 202.06%
JP
Tikun Olam-Cannbit Pharmaceuticals Ltd Tikun Olam-Cannbit Pharmaceuticals Ltd
Tikun Olam-Cannbit Pharmaceuticals Ltd
TKUN.TA
 $9.82M -99.90%
IL
Haleon plc Haleon plc
Haleon plc
HLN.US
 $25.92B 173.79%
GB